DUBAI: SAP SE (NYSE: SAP) has announced the launch of its vaccine collaboration hub (VCH) for organizations to better manage vaccine supply distribution, and to help governments and their industry partners coordinate and successfully deploy mass vaccination programs.
SAP’s VCH is built on the industry-award-winning SAP Information Collaboration Hub for Life Sciences. It covers the end-to-end process from manufacturing to controlled distribution to administration and postvaccine monitoring.
“COVID-19 has put a lot of pressure on the life sciences industry where they have realized a large gap in their supply chain strategy,” said Michael Townsend, industry analyst at IDC. “A one-stop place for the life sciences industry to manage their vaccination procedures and tap into a source of suppliers, even those across industries, will help to fill this gap, to ensure patients obtain lifesaving drugs and devices.”
Businesses that are part of the vaccine production process, from manufacturers, logistics service providers and pharma companies to wholesalers and dispensers, can run their critical vaccine processes on SAP software. Building on its deep expertise in the industry, SAP has designed the VCH as an extension to its business network–enabled drug supply chain, to help make collaboration among the network partners easy and monitor the order fulfillment of vaccines, all the way from vaccine suppliers to the dispensing units.
The VCH, part of SAP’s industry cloud strategy, is designed to address specific industry needs. It provides the critical network and technology capabilities required to effectively support large-scale vaccination programs and drug distribution, while creating the backbone to better mitigate future emergencies.
-Ends-
© Press Release 2020
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
